Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Vancouver, Jan. 18, 2024 (GLOBE NEWSWIRE) -- The global insulin delivery devices market size was USD 13.37 billion in 2022 and is expected to register a revenue CAGR of 7.5% during the forecast...
-
New York, Jan. 09, 2024 (GLOBE NEWSWIRE) -- The global Insulin Pens market is undergoing substantial growth, driven by the increasing prevalence of diabetes, advancements in insulin delivery...
-
Pune, India, Nov. 20, 2023 (GLOBE NEWSWIRE) -- The smart insulin pens market is expected to expand from USD 755.4 million in 2023 to USD 1,514.6 million by 2030, exhibiting a CAGR of 10.4% over the...
-
New York, May 24, 2023 (GLOBE NEWSWIRE) -- As per Market.us, a provider of market research and competitive intelligence, the Diabetes Devices Market size is projected to surpass around USD 68.2...
-
New York, March 22, 2023 (GLOBE NEWSWIRE) -- The Injectable Drug Delivery Market was about US$ 41.5 Billion in 2022 to US$ 101.2 Billion by 2033, With at a CAGR of 8.4%. Injectable drug delivery...
-
Rockville, March 03, 2023 (GLOBE NEWSWIRE) -- The global insulin delivery devices market is poised to expand at 7% CAGR during the forecast period (2023 to 2033). Worldwide insulin delivery device...
-
NEWARK, Del, Jan. 12, 2023 (GLOBE NEWSWIRE) -- The global Insulin Pens Market is valued at US$ 35 billion in 2023. The market is expected to advance at a CAGR of 6.5% during the period 2023-2033....
-
New York, USA, Sept. 19, 2022 (GLOBE NEWSWIRE) -- Smart Insulin Pens Market Overview According to a Comprehensive Research Report by Market Research Future (MRFR), “Smart Insulin Pens Market...
-
Selbyville, Delaware, Jan. 25, 2021 (GLOBE NEWSWIRE) -- According to latest report “Digital Diabetes Management Market by Product Type (Devices, , Services), Patient Type (Type 1, Type 2), End-Use...
-
New York, Aug. 26, 2019 (GLOBE NEWSWIRE) -- Prevalence of diabetes, product launches and continuous research and development key factors contributing to high CAGR of Insulin Delivery Devices during...